We are live on
!
Find out more
Vise Technologies Portfolio holdings
AUM
$8.83B
Turnover
36.58%
1-Year Est. Return
27.11%
This Fund
S&P 500
This Quarter
Est. Return
-1.82%
1 Year Est. Return
+27.11%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.09B
AUM Growth
-$12M
(-0.24%)
Cap. Flow
-$12.2M
Cap. Flow
% of AUM
-0.24%
Top 10 Holdings %
Top 10 Hldgs %
26.69%
Holding
1,461
New
–
Increased
–
Reduced
3
Closed
14
Avg Time Held
1.3
years
Top 10 Avg Time Held
0.8
years
Top 20 Avg Time Held
1.2
years
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$5.19M |
| 2 |
Frontier Communications
FYBR
|
+$1.31M |
| 3 |
Amcor
AMCR
|
+$1.21M |
| 4 |
Exact Sciences
EXAS
|
+$1.19M |
| 5 |
Piper Sandler
PIPR
|
+$932K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 52.26% |
| 2 | Technology | 15.38% |
| 3 | Financials | 8.06% |
| 4 | Consumer Discretionary | 4.73% |
| 5 | Communication Services | 4.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1076
Factset
FDS
$10.7B
| $342K | 0.01% |
1,178
| – | – |
2025 Q4
1 quarter
|
|
1077
iShares Currency Hedged MSCI EAFE ETF
HEFA
$7.51B
| $341K | 0.01% |
8,237
| – | – |
2025 Q2
3 quarters
|
|
1078
Ionis Pharmaceuticals
IONS
$7.14B
| $341K | 0.01% |
4,305
| – | – |
2025 Q4
1 quarter
|
|
1079
Simpson Manufacturing
SSD
$7.23B
| $340K | 0.01% |
2,108
| – | – |
2025 Q4
1 quarter
|
|
1080
MongoDB
MDB
$27.2B
| $339K | 0.01% |
807
| – | – |
2025 Q3
2 quarters
|
|
1081
Veralto
VLTO
$24.6B
| $338K | 0.01% |
3,390
| – | – |
2025 Q2
3 quarters
|
|
1082
Spire
SR
$4.85B
| $337K | 0.01% |
4,069
| – | – |
2025 Q3
2 quarters
|
|
1083
Ardelyx
ARDX
$798M
| $336K | 0.01% |
57,638
| – | – |
2025 Q4
1 quarter
|
|
1084
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
$2.6B
| $335K | 0.01% |
7,306
| – | – |
2025 Q4
1 quarter
|
|
1085
Houlihan Lokey
HLI
$9.05B
| $334K | 0.01% |
1,919
| – | – |
2025 Q2
3 quarters
|
|
1086
Manitowoc
MTW
$777M
| $334K | 0.01% |
27,877
| – | – |
2025 Q2
3 quarters
|
|
1087
Rambus
RMBS
$9.46B
| $333K | 0.01% |
3,627
| – | – |
2025 Q3
2 quarters
|
|
1088
Maximus
MMS
$3.22B
| $333K | 0.01% |
3,853
| – | – |
2025 Q2
3 quarters
|
|
1089
Liberty Media Corporation Series C Common Stock
FWONK
$22.8B
| $332K | 0.01% |
3,370
| – | – |
2025 Q4
1 quarter
|
|
1090
JPMorgan Active Growth ETF
JGRO
$9.73B
| $332K | 0.01% |
3,576
| – | – |
2025 Q4
1 quarter
|
|
1091
WisdomTree US Quality Growth Fund
QGRW
$3.19B
| $332K | 0.01% |
5,653
| – | – |
2025 Q4
1 quarter
|
|
1092
Franklin International Core Dividend Tilt Index ETF
DIVI
$2.64B
| $331K | 0.01% |
8,523
| – | – |
2025 Q4
1 quarter
|
|
1093
Lumentum
LITE
$74.7B
| $331K | 0.01% |
899
| – | – |
2025 Q4
1 quarter
|
|
1094
Dr. Reddy's Laboratories
RDY
$10.9B
| $331K | 0.01% |
23,603
| – | – |
2025 Q2
3 quarters
|
|
1095
Invesco California AMT-Free Municipal Bond ETF
PWZ
$1.17B
| $330K | 0.01% |
13,674
| – | – |
2025 Q4
1 quarter
|
|
1096
Schneider National
SNDR
$5.52B
| $329K | 0.01% |
12,417
| – | – |
2024 Q4
5 quarters
|
|
1097
H&R Block
HRB
$5.96B
| $329K | 0.01% |
7,548
| – | – |
2025 Q2
3 quarters
|
|
1098
Pan American Silver
PAAS
$18.3B
| $326K | 0.01% |
6,295
| – | – |
2025 Q3
2 quarters
|
|
1099
State Street SPDR Portfolio High Yield Bond ETF
SPHY
$11.8B
| $326K | 0.01% |
13,772
| – | – |
2022 Q3
14 quarters
|
|
1100
BCE
BCE
$19B
| $326K | 0.01% |
13,680
| – | – |
2025 Q2
3 quarters
|
|
Similar funds
GRQ
Vise Technologies's Q1 2026 Portfolio in Review
As of Q1 2026, Vise Technologies held 1,461 positions worth $5.09B, down 0.24% from $5.1B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Trading was light in Q1 2026: portfolio turnover was 0.96%. Vise Technologies opened no new positions and exited 14, leaving the 1,461-position portfolio largely intact.
By sector, the portfolio is most concentrated in Miscellaneous at 52% of assets, up from 52% a quarter earlier, followed by Technology and Financials.
- Vise Technologies's biggest Q1 2026 reduction was StoneX, cutting an estimated $101K.
- Vise Technologies fully exited AstraZeneca in Q1 2026, selling an estimated $5.19M.
- Vise Technologies's ten largest holdings make up 27% of its $5.09B portfolio in Q1 2026.
- Vise Technologies opened 0 new positions and closed 14 in Q1 2026.
- Vise Technologies's portfolio value fell 0.24% quarter-over-quarter to $5.09B.
Based on Vise Technologies's 13F filing for Q1 2026, filed 21 Apr 2026.